Treatment with resveratrol attenuates sublesional bone loss in spinal cord‐injured rats
暂无分享,去创建一个
S. Hou | Hua-dong Wang | Ji-dong Guo | Li Li | Ya-min Shi | Yu-peng Zhang
[1] Timothy M. Errington,et al. Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota , 2018, eLife.
[2] Fanxin Long,et al. β‐catenin promotes bone formation and suppresses bone resorption in postnatal growing mice , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] F. Shuang,et al. Treatment of hydrogen molecule abates oxidative stress and alleviates bone loss induced by modeled microgravity in rats , 2013, Osteoporosis International.
[4] Lei-Sheng Jiang,et al. Spinal cord injury causes bone loss through peroxisome proliferator-activated receptor-γ and Wnt signalling , 2012, Journal of cellular and molecular medicine.
[5] L. Giangregorio,et al. Serum 25(OH)D, PTH and Correlates of Suboptimal 25(OH)D Levels in Persons with Chronic Spinal Cord Injury , 2012, Spinal Cord.
[6] A. Mobasheri,et al. Resveratrol Mediated Modulation of Sirt-1/Runx2 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells: Potential Role of Runx2 Deacetylation , 2012, PloS one.
[7] L. Morse,et al. Severe Spinal Cord Injury Causes Immediate Multi-cellular Dysfunction at the Chondro-Osseous Junction , 2011, Translational Stroke Research.
[8] Stephen P. H. Alexander,et al. Guide to Receptors and Channels (GRAC), 5th edition , 2011, British journal of pharmacology.
[9] H. Zhu,et al. Oxidative stress in spinal cord injury and antioxidant-based intervention , 2011, Spinal Cord.
[10] L. Dai,et al. Down-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in osteoblasts from rats with chronic spinal cord injury. , 2011, Joint, bone, spine : revue du rhumatisme.
[11] D. Desplanches,et al. Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[12] Kunzheng Wang,et al. Resveratrol improves neuron protection and functional recovery in rat model of spinal cord injury , 2011, Brain Research.
[13] David Brasse,et al. Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension , 2011, Journal of Bone and Mineral Metabolism.
[14] A. Mobasheri,et al. Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-κB Ligand (RANKL) Activation of NF-κB Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells , 2011, The Journal of Biological Chemistry.
[15] G. Andersson,et al. Resveratrol prevents RANKL-induced osteoclast differentiation of murine osteoclast progenitor RAW 264.7 cells through inhibition of ROS production. , 2010, Biochemical and biophysical research communications.
[16] C. Kilkenny,et al. Guidelines for reporting experiments involving animals: the ARRIVE guidelines , 2010, British journal of pharmacology.
[17] T. Szkudelski,et al. Resveratrol, obesity and diabetes. , 2010, European journal of pharmacology.
[18] Xiyu Zhang,et al. Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells. , 2009, Experimental cell research.
[19] G. Burdock,et al. Safety studies conducted on high-purity trans-resveratrol in experimental animals. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[20] M. Almeida,et al. Increased Lipid Oxidation Causes Oxidative Stress, Increased Peroxisome Proliferator-activated Receptor-γ Expression, and Diminished Pro-osteogenic Wnt Signaling in the Skeleton* , 2009, The Journal of Biological Chemistry.
[21] L. Dai,et al. Effects of spinal cord injury and hindlimb immobilization on sublesional and supralesional bones in young growing rats. , 2008, Bone.
[22] R. Müller,et al. Spinal cord injury causes rapid osteoclastic resorption and growth plate abnormalities in growing rats (SCI-induced bone loss in growing rats) , 2008, Osteoporosis International.
[23] J A Peters,et al. Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.
[24] Matthew R Allen,et al. Mechanical Stimulation of Bone in Vivo Reduces Osteocyte Expression of Sost/Sclerostin* , 2008, Journal of Biological Chemistry.
[25] Y. Wan,et al. PPAR-γ regulates osteoclastogenesis in mice , 2007, Nature Medicine.
[26] L. Dai,et al. Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats , 2007, Osteoporosis International.
[27] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[28] L. Dai,et al. Mechanisms of osteoporosis in spinal cord injury , 2006, Clinical endocrinology.
[29] N. Ishimaru,et al. Ubiquitin Ligase Cbl‐b Downregulates Bone Formation Through Suppression of IGF‐I Signaling in Osteoblasts During Denervation , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[30] C E Webber,et al. Body weight supported treadmill training in acute spinal cord injury: impact on muscle and bone , 2005, Spinal Cord.
[31] W. Li,et al. Effects of trans-resveratrol from Polygonum cuspidatum on bone loss using the ovariectomized rat model. , 2005, Journal of medicinal food.
[32] Ying-bao Yang,et al. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. , 2003, Acta pharmacologica Sinica.
[33] Y. Maugars,et al. Supralesional and sublesional bone mineral density in spinal cord-injured patients. , 2000, Bone.
[34] R. Jilka,et al. Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARγ2 , 1999, Journal of cellular biochemistry.
[35] N. Paker,et al. Osteoporosis after spinal cord injury , 1998, Spinal Cord.
[36] P. Fondu,et al. Increased Osteoclast-Like Cells Formation in Long-Term Bone Marrow Cultures from Patients with a Spinal Cord Injury , 1998, Calcified Tissue International.
[37] K. Klose,et al. Evaluation of a training program for persons with SCI paraplegia using the Parastep 1 ambulation system: part 3. Lack of effect on bone mineral density. , 1997, Archives of physical medicine and rehabilitation.
[38] A. Parfitt,et al. Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. , 1996, The Journal of clinical investigation.
[39] P. Bergmann,et al. Longitudinal study of the bone mineral content and of soft tissue composition after spinal cord section , 1995, Paraplegia.
[40] S. Mohan,et al. The insulin-like growth factor system and the coupling of formation to resorption. , 1995, Bone.
[41] Toshitaka Nakamura,et al. Intermittent cyclical etidronate treatment maintains the mass, structure and the mechanical property of bone in ovariectomized rats , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[42] A. Spungen,et al. Blunted Growth Hormone Response to Intravenous Arginine in Subjects with a Spinal Cord Injury , 1994, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[43] C. Sutton,et al. Hyposomatomedinemia in quadriplegic men. , 1993, The American journal of the medical sciences.
[44] R. Adkins,et al. Osteoporosis after spinal cord injury , 1992, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[45] P. Pietschmann,et al. Increased serum osteocalcin levels in patients with paraplegia , 1992, Paraplegia.
[46] A. Parfitt. Bone histomorphometry: standardization of nomenclature, symbols and units. Summary of proposed system. , 1988, Bone and mineral.
[47] M. Drezner,et al. Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987 .
[48] A. Robling,et al. Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. , 2012, Bone.
[49] L. Peshkin,et al. Supplemental Data Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life Span , 2008 .
[50] W. Chiu,et al. Gene transfer of insulin-like growth factor-I providing neuroprotection after spinal cord injury in rats. , 2007, Journal of neurosurgery. Spine.
[51] Y. Wan,et al. PPAR-gamma regulates osteoclastogenesis in mice. , 2007, Nature medicine.
[52] L. Harvey,et al. Does 12 weeks of regular standing prevent loss of ankle mobility and bone mineral density in people with recent spinal cord injuries? , 2005, The Australian journal of physiotherapy.
[53] Paula Kocina. Body Composition of Spinal Cord Injured Adults , 1997, Sports medicine.
[54] L. Mosekilde,et al. The effect of aging and ovariectomy on the vertebral bone mass and biomechanical properties of mature rats. , 1993, Bone.
[55] R. Weinstein. The Effects of Androgen Deficiency on Murine Bone Remodeling and Bone Mineral Density Are Mediated via Cells of the Osteoblastic Lineage* , 2022 .